Integrating lifestyle changes with customized medical care is imperative for success. By Laura M. Periman, MD When we consider the updated definition of dry eye disease (DED) from 2017 TFOS DEWS II, we...

A study compared the iStent Inject, Kahook Dual Blade (KDB), Trabectome, and Hydrus Microstent and found KDB to be most cost-effective in terms of cost per mmHG of IOP reduction.

Total rectus volume is predictive of proptosis reduction following treatment with teprotumumab in patients with thyroid eye disease (TED), according to a study that examined potentially predictive baseline imaging characteristics. Of the 25...

The U.S. Food and Drug Administration has approved Luminopia One (Luminopia) as a prescription therapy to improve vision in children with amblyopia (lazy eye), the leading cause of vision loss in children, according...